News
Of the 224 companies analyzed, 98 received a clinical robustness score of zero.
This follows last year's FDA approvals in the US.
Also: Oma Fertility emerges from stealth with $37.5 million in equity and debt financing, and payer data platform Abacus Insights scores $28 million.
Equip CEO and cofounder Kristina Saffran discusses the virtual eating disorder treatment startup's nationwide expansion and why the space needs more research and innovation.
The company is leveraging its own portfolio and partner digital assets to directly engage patients at home, virtually or in-person.
The startup's smartphone-administered digital therapeutic for fibromyalgia received FDA Breakthrough Device designation last year.
Also, Nordic nurse-tech pioneer to launch in the UK.
It will use the funds to deepen its presence across Asia.
The company has also launched a distribution unit in the United States.
The company plans to bring its technology to 10,000 more doctors in the country.